The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Determinants of Cognitive Function in Individuals with Type 2 Diabetes Mellitus: A Meta-Analysis
Abstract
Background: Type 2 diabetes mellitus (T2DM) is associated with deficits across multiple cognitive domains; however, the determinants of cognitive impairment in T2DM are not well characterized. We aimed to evaluate body mass index (BMI), glycemic control, and T2DM duration as moderators of cognitive dysfunction in T2DM. Methods: We conducted a meta-analytic review of the literature reporting data on BMI, hemoglobin A lc (HbA lc ), T2DM duration, and validated measures of processing speed (ie, Digit Symbol Substitution Test, Trail Making Test [TMT]-A), verbal learning and memory (ie, Rey Auditory Verbal Learning Test), and working memory/executive function (ie, TMT-B) among individuals with vs without T2DM. Results: Individuals with T2DM demonstrated deficits across multiple cognitive domains (/c = 40; n = 4,252 T2DM; n = 22,322 non-T2DM; effect sizes 0.21 to 0.35). Illness duration and BMI did not significantly moderate measures of cognition; however, higher HbA lc levels were significantly associated with deficits in measures of processing speed ( R 2 values 0.41 to 0.73, P < .01) and working memory/executive function ( R 2 = 0.62, P <.001). Conclusions: Adults with T2DM exhibited significant deficits across multiple domains of cognitive function. Additionally, we identified an association between poorer glycemic control and cognitive dysfunction. A clinical translation of our findings relates to the reduction in morbidity by improving glycemie control.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notwithstanding the inconsistent evidence, lisdexamfetamine has been shown to specifically target and improve deficits in executive function in individuals with MDD, particularly among individuals with milder cognitive symptoms comorbid with executive function deficits.69”
From Cognitive Impairment in Major Depressive Disorder (2019) · cites this paper as [69]
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies
Cukierman, T., Gerstein, H. C., & Williamson, J. D. (2005) · Diabetologia · doi:10.1007/s00125-005-0023-4 · Cited by 1,049
Self-citationDiabetes and cognitive dysfunction
McCrimmon, R. J., Ryan, C. M., & Frier, B. M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60360-2 · Cited by 880
Elevated body mass index is associated with executive dysfunction in otherwise healthy adults
Gunstad, J., Paul, R. H., Cohen, R. A., Tate, D. F., Spitznagel, M. B., & Gordon, E. (2007) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2006.05.001 · Cited by 668 · cited 11×
“When compared with non-T2DM controls, individuals with T2DM performed worse on the DSST (SMD = −0.35, 95% confidence interval [CI] = −0.43, −0.27, P .001), RAVLT (SMD = −0.21, 95% CI = −0.33, −0.09, P .001), TMT-A (SMD = 0.31, 95% CI = 0.15, 0.48, P .001), and TMT-B (SMD = 0.27, 95% CI = 0.13, 0.41, P .001) ( FIGURE 2…”
InfluentialStrachan, M. W. J., Deary, I. J., Ewing, F. M. E., & Frier, B. M. (1997) · Diabetes Care · doi:10.2337/diacare.20.3.438 · Cited by 529
Is Diabetes Associated With Cognitive Impairment and Cognitive Decline Among Older Women?
Gregg, E. W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.2.174 · Cited by 521
Diabetes, impaired fasting glucose, and development of cognitive impairment in older women
Yaffe, K., Blackwell, T., Kanaya, A. M., Davidowitz, N., Barrett-Connor, E., & Krueger, K. (2004) · Neurology · doi:10.1212/01.wnl.0000134666.64593.ba · Cited by 520
Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes
Gold, S. M., Dziobek, I., Sweat, V., Tirsi, A., Rogers, K., Bruehl, H., Tsui, W., Richardson, S., Javier, E., & Convit, A. (2007) · Diabetologia · doi:10.1007/s00125-007-0602-7 · Cited by 489 · cited 1×
“1,3,5,6 The hetero geneity in study findings may, in part, be explained by differences in sample composition, cognitive assessment tools, and T2DM-related pathoetiological disturbances.”
Cukierman-Yaffe, T., Gerstein, H. C., Williamson, J. D., Lazar, R. M., Lovato, L., Miller, M. E., Coker, L. H., Murray, A., Sullivan, M. D., Marcovina, S. M., et al. (2009) · Diabetes Care · doi:10.2337/dc08-1153 · Cited by 452
Self-citationDiabetes in Midlife and Cognitive Change Over 20 Years: A Cohort Study
Rawlings, A. M., Sharrett, A. R., Schneider, A. L. C., Coresh, J., Albert, M., Couper, D., Griswold, M., Gottesman, R. F., Wagenknecht, L. E., Windham, B. G., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0737 · Cited by 447
Research works printed but not linked: 1
- AreosaSA Grimley EV Effect of the treatment of type II diabetes mellitus on the development of cognitive impairment and dementia. Cochrane Database Syst Rev. 2002;(4):CD003804.
Cited by
Type 2 diabetes mellitus in older adults: clinical considerations and management
Bellary, S., Kyrou, I., Brown, J. E., & Bailey, C. J. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00512-2 · Cited by 639
Cognitive Impairment in Major Depressive Disorder
Pan, Z., Park, C., Brietzke, E., Zuckerman, H., Rong, C., Mansur, R. B., Fus, D., Subramaniapillai, M., Lee, Y., & McIntyre, R. S. (2019) · CNS Spectrums · doi:10.1017/s1092852918001207 · Cited by 320
“Moreover, evidence from a recent meta-analysis showed that reductions in cognitive function are predictive of poorer functional andmetabolic outcomes.(14) Despite the foregoing evidence, current antidepressant regimens do not primarily target psychosocial impairments and workplace disability in MDD.”
BackgroundSelf-citationBrain insulin resistance: A treatment target for cognitive impairment and anhedonia in depression
Hamer, J., Testani, D. A., Mansur, R. B., Lee, Y. L., Subramaniapillai, M., & McIntyre, R. S. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.01.016 · Cited by 146
Self-citationKe, C., Lau, E. S. H., Shah, B. R., Stukel, T. A., Ronald, C. W., So, W., Kong, A. P. S., Chow, E., Clarke, P., Goggins, W. B., et al. (2019) · Annals of Internal Medicine · doi:10.7326/m18-1900 · Cited by 95
“Diabetes may alter brain connectivity and cause cognitive dysfunction (35), which may worsen schizophrenia (37).”
BackgroundDefo, A. K., Bakula, V., Pisaturo, A., Labos, C., Wing, S. S., & Daskalopoulou, S. S. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15331 · Cited by 87
Metadata
- Authors
- Mansur, R. B., Lee, Y., Zhou, A. J., Carmona, N. E., Cha, D. S., Rosenblat, J. D., Bruins, R., Kakar, R., Rasgon, N. L., Lovshin, J. A., Wroolie, T. E., Sim, K., Brietzke, E., Gerstein, H. C., Rong, C., & Mclntyre, R. S.
- Affiliations
- University Health Network (CA)
- University of Toronto (CA)
- Eli Lilly (Canada) (CA)
- Stanford Medicine (US)
- Mount Sinai Hospital (CA)
- Institute of Mental Health (SG)
- Universidade Federal de São Paulo (BR)
- Population Health Research Institute (CA)
- Corresponding author
- Mclntyre, Roger S.
- ORCID
- Venue
- Annals of Clinical Psychiatry
- Publisher
- SAGE Publications
- Published
- 2018-02
- Volume
- 30
- Issue
- 1
- Pages
- 38-50
- ISSN
- 1040-1237 (ISSN-L)
- 1547-3325
- OpenAlex
- W2981780637
- Cited by
- 64
- References
- 71
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 7 · 2023: 7 · 2022: 10 · 2021: 7 · 2020: 9 · 2019: 8 · 2018: 4
- FWCI
- 1.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Annals of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- type 2 diabetes, cognitive impairment, glycemic control, HbA1c, body mass index, diabetes duration, processing speed, working memory, executive function, verbal learning and memory
- MeSH terms
- Diabetes Mellitus, Type 2, Glycated Hemoglobin, Humans, Neuropsychological Tests, Diabetes Complications, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Determinants of Cognitive Function in Individuals with Type 2 Diabetes Mellitus: A Meta-Analysis. https://app.cochat.ai/papers/10.1177/154733251803000107
- The paper
- Mansur, R. B., Lee, Y., Zhou, A. J., Carmona, N. E., Cha, D. S., Rosenblat, J. D., Bruins, R., Kakar, R., Rasgon, N. L., Lovshin, J. A., Wroolie, T. E., Sim, K., Brietzke, E., Gerstein, H. C., Rong, C., & Mclntyre, R. S. (2018). Determinants of Cognitive Function in Individuals with Type 2 Diabetes Mellitus: A Meta-Analysis. Annals of Clinical Psychiatry. https://doi.org/10.1177/154733251803000107
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.